Choline bitartrate Market Expected to Reach $736.2 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Choline bitartrate Market," The choline bitartrate market was valued at $410.2 million in 2021, and is estimated to reach $736.2 million by 2031, growing at a CAGR of 6.1% from 2022 to 2031.

Choline bitartrate is utilized in the different wellbeing-related issues. It is primarily utilized in dietary supplements. Choline supplements are used to lower cholesterol, reduce mood swings, and protect the liver from alcohol damage. Besides, choline bitartrate can also lower blood pressure, improve memory and treat Alzheimer's disease. Choline can also improve athletic performance and helps prevent neural tube defects during pregnancy. Its acceptance in the infant  dietary food, supplementary dietary foods, foods & beverages industry will drive the market demand. Rising awareness regarding essential nutrition and growing emphasis on preventive health care will propel the demand for choline bitartrate in upcoming years. 

The choline bitartrate industry is classified into type, application, and region. On the basis of type, the market is segmented into DL, D, and L. On the basis of application, the market is divided into pharmaceutical & nutritional supplement, food & beverage, baby food, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the regions, North America held the highest share of the global choline bitartrate market in 2021 owing to increase in demand for baby food and infant formula products.

The key players included in the report include Balchem Inc.; Celtic Chemicals Ltd; Cepham Life Sciences; Fengchen Group Co., Ltd; Glentham Life Sciences Ltd; MP Biomedicals; Nutragreenlife Biotechnology Co., Ltd; NutriSciences Innovations, LLC; Puyer Group; and TOKYO CHEMICAL INDUSTRY CO., LTD. Other players in the value chain of the choline bitartrate market include Arochem, SALVI CHEMICAL INDUSTRIES LTD., Acros Organics BVBA, Aurora Fine Chemicals LLC, Finetech Industry Limited, AHH Chemical co., ltd, abcr GmbH, AK Scientific Inc. 

COVID-19 analysis

The COVID-19 pandemic has had extraordinary consequences on the choline bitartrate market's end-use industries. It also has an influence on the supply of active materials and ingredients (mostly from China), as well as the import and export of pharmaceutical products, where demand has increased to strengthen people's immunity. Physical barriers, such as the skin and gut epithelium, are part of the innate immune system and assist prevent pathogen entrance. It also comprises leukocytes (white blood cells) that try to locate and eradicate invading infections, such as neutrophils, macrophages (which release cytokines), and natural killer cells. However, health concerns were not taken seriously before the COVID-19 outbreak. Due to the COVID-19 outbreak, the health awareness among the populace has grown and the pharmaceutical sector has benefited from dietary supplements. The growing demand for dietary supplements is predicted to drive the market for choline bitartrate globally during the COVID-19 pandemic.

Key Findings of Study

• By region, North America accounted for the largest global choline bitartrate market share in 2021.
• By type, the L segment is projected to grow at the highest CAGR during the choline bitartrate market forecast period.
• By application, the pharmaceutical & nutritional supplement segment is expected to dominate the global choline bitartrate market during the forecast period.